Alikhan N F, Petty N K, Zakour N L B, Beatson S A. 2011. Blast ring image generator (BRIG): Simple prokaryote genome comparisons. BMC Genomics, 12, 402.

Álvarez-Marín R, Navarro-Amuedo D, Gasch-Blasi O, Rodríguez-Martínez J M, Calvo-Montes J, Lara-Contreras R, Lepe-Jiménez J A, Tubau-Quintano F, Cano-García M E, Rodríguez-López F, Rodríguez-Baño J, Pujol-Rojo M, Torre-Cisneros J, Martínez-Martínez L, Pascual-Hernández Á, Jiménez-Mejías M E. 2020. A prospective, multicenter case-control study of risk factors for acquisition and mortality in Enterobacter species bacteremia. Journal of Infection, 80, 2.

Band V I, Crispell E K, Napier B A, Herrera C M, Tharp G K, Vavikolanu K, Pohl J, Read T D, Bosinger S E, Trent M S, Burd E M, Weiss D S. 2016. Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae. Nature Microbiology, 9, 16053.

Band V I, Satola S W, Smith R D, Hufnagel D A, Bower C, Conley A B, Rishishwar L, Dale S E, Hardy D J, Vargas R L, Dumyati G, Kainer M A, Phipps E C, Pierce R, Wilson L E, Sorensen M, Nilsson E, Jordan I K, Burd E M, Farley M M, et al. 2021. Colistin heteroresistance is largely undetected among carbapenem-resistant Enterobacterales in the United States. mBio, 26, 12.

Börjesson S, Michael S M B, Östlund E, Lindsjö K O, Engblom L I. 2022. Detection of an IMI-2 carbapenemase-producing Enterobacter asburiae at a Swedish feed mill. Frontiers in Microbiology, 13, 993454.

Brooke A N, Victor B, Eileen M B, David S W. 2014. Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrobial Agents and Chemotherapy, 58, 5594–5597.

Chin C S, Alexander D H, Marks P, Klammer A A, Drake J, Heiner C, Clum A, Copeland A, Huddleston J, Eichler E E, Turner S W, Korlach J. 2013. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nature Methods, 10, 563–569.

CLSI M100 ED 30-2020. 2020. Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute, USA. 30th ed.

Chu Y W, Tung V W, Cheung T K, Chu M Y, Cheng N, Lai C, Tsang D N, Lo J Y. 2011. Carbapenemases in Enterobacteria, Hong Kong, China, 2009. Emerging Infectious Diseases, 17, 130–132.

Dang B, Mao D, Luo Y. 2016. Complete nucleotide sequence of pGA45, a 140,698-bp IncFIIY plasmid encoding blaIMI-3- mediated carbapenem resistance, from river sediment. Frontiers in Microbiology, 24, 188.

Davin-Regli A, Pages J M. 2015. Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment. Frontiers in Microbiology, 6, 392.

Doi Y. 2019. Treatment options for carbapenem-resistant Gram-negative bacterial infections. Clinical Infectious Diseases, 69, 565–575.

El-Sayed Ahmed M A E, Zhong L L, Shen C, Yang Y, Doi Y, Tian G B. 2020. Colistin and its role in the era of antibiotic resistance: an extended review (2000–2019). Emerging Microbes & Infection, 9, 868–885.

Espeli O, Nurse P, Levine C, Lee C, Marians K J. 2003. SetB: an integral membrane protein that affects chromosome segregation in Escherichia coli. Molecular Microbiology, 50, 495–509.

EUCAST (European Committee on Antimicrobial Susceptibility Testing). 2022. Breakpoint Tables for Interpretation of MICs and Zone Diameters. version 12.0. EUCAST, Växjö.

Gomi R, Matsumura Y, Tanaka M, Ihara M, Sugie Y, Matsuda T, Yamamoto M. 2022. Emergence of rare carbapenemases (FRI, GES-5, IMI, SFC and SFH-1) in Enterobacterales isolated from surface waters in Japan. Journal of Antimicrobial Chemotherapy, 77, 1237–1246.

Gong G, Um Y, Park T H, Woo H M. 2015. Complete genome sequence of Enterobacter cloacae GGT036: a furfural tolerant soil bacterium. Journal of Biotechnology, 193, 43–44.

Hermanns U, Sebbel P, Eggli V, Glockshuber R. 2000. Characterization of FimC, a periplasmic assembly factor for biogenesis of type 1 pili in Escherichia coli. Biochemistry, 39, 11564–11570.

Hopkins K L, Findlay J, Doumith M, Mather B, Meunier D, D’Arcy S, Pike R, Mustafa N, Howe R, Wootton M, Woodford N. 2017. IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK. Journal of Antimicrobial Chemotherapy, 72, 2129–2131.

Huang L, Feng Y, Zong Z. 2019. Heterogeneous resistance to colistin in Enterobacter cloacae complex due to a new small transmembrane protein. Journal of Antimicrobial Chemotherapy, 74, 2551–2558.

Huang L, Wang X, Feng Y, Xie Y, Xie L, Zong Z. 2015. First identification of an IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae in China. Annals of Clinical Microbiology Antimicrobials, 14, 51.

Jin C, Zhou F, Cui Q, Qiang J, An C. 2020. Molecular characteristics of carbapenem-resistant Enterobacter cloacae in a tertiary hospital in China. Infection and Drug Resistance, 13, 1575–1581.

Li H, Durbin R. 2010. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics, 26, 589–595.

Liao Q, Lam W T, Leung G M, Jiang C, Fielding R. 2009. Live poultry exposure, Guangzhou, China, 2006. Epidemics, 1, 207–212.

Mashaly G E, Mashaly M E. 2021. Colistin-heteroresistance in carbapenemase-producing Enterobacter species causing hospital-acquired infections among Egyptian patients. Journal of Global Antimicrobial Resistance, 24, 108–113.

Mezzatesta M L, Gona F, Stefani S. 2012. Enterobacter cloacae complex: Clinical impact and emerging antibiotic resistance. Future Microbiology, 7, 887–902.

Miltgen G, Cholley P, Martak D, Thouverez M, Seraphin P, Leclaire A, Traversier N, Roquebert B, Jaffar-Bandjee M C, Lugagne N, Cimon C B, Ramiandrisoa M, Picot S, Lignereux A, Masson G, Allyn J, Allou N, Mavingui P, Belmonte O, Bertrand X, et al. 2020. Carbapenemase-producing Enterobacteriaceae circulating in the Reunion Island, a French territory in the Southwest Indian Ocean. Antimicrobial Resistance and Infection Control, 9, 36.

Norgan A P, Freese J M, Tuin P M, Cunningham S A, Jeraldo P R, Patel R. 2016. Carbapenem- and colistin-resistant Enterobacter cloacae from Delta, Colorado, in 2015. Antimicrobial Agents and Chemotherapy, 60, 3141–3144.

Rasmussen B A, Bush K, Keeney D, Yang Y, Hare R, O’gara C, Medeiros A A. 1996. Characterization of IMI-1 β-lactamase, a Class A carbapenem hydrolyzing enzyme from Enterobacter cloacae. Antimicrobial Agents and Chemotherapy, 40, 6.

Reuven N B, Arad G, Maor-Shoshani A, Livneh Z. 1999. The mutagenesis protein UmuC is a DNA polymerase activated by UmuD, RecA, and SSB and is specialized for translesion replication. Journal of Biology Chemistry, 274, 31763–31766.

Rojo-Bezares B, Martin C, Lopez M, Torres C, Saenz Y. 2012. First detection of blaIMI-2 gene in a clinical Escherichia coli strain. Antimicrobial Agents and Chemotherapy, 56, 1146–1147.

Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics, 30, 2068–2069.

Suay-Garcia B, Perez-Gracia M T. 2019. Present and future of carbapenem-resistant Enterobacteriaceae (CRE) infections. Antibiotics (Basel), 8, 122.

Sugawara Y, Hagiya H, Akeda Y, Aye M M, Myo Win H P, Sakamoto N, Shanmugakani R K, Takeuchi D, Nishi I, Ueda A, Htun M M, Tomono K, Hamada S. 2019. Dissemination of carbapenemase-producing Enterobacteriaceae harbouring blaNDM or blaIMI in local market foods of Yangon, Myanmar. Scientific Reports, 9,14455.

Sullivan M J, Petty N K, Beatson S A. 2011. Easyfig: A genome comparison visualizer. Bioinformatics, 27, 1009–1010.

Telke A A, Olaitan A O, Morand S, Rolain J M. 2017. SoxRS induces colistin hetero-resistance in Enterobacter asburiae and Enterobacter cloacae by regulating the acrAB–tolC efflux pump. Journal Antimicrobial Chemotherapy, 72, 2715–2721.

Xue Y, Hu M, Chen S, Hu A, Li S, Han H, Lu G, Zeng L, Zhou J. 2021. Enterobacter asburiae and Pantoea ananatis causing rice bacterial blight in China. Plant Disease, 105, 2078–2088.

Yawei Z, Wang Q, Yin Y, Chen H. 2018. Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE network. Antimicrobial Agents and Chemotherapy, 62, 1882–1917.

Zhang F, Wang X, Xie L, Zheng Q, Guo X, Han L, Sun J. 2017. A novel transposon, Tn6306, mediates the spread of blaIMI in Enterobacteriaceae in hospitals. International Journal of Infectious Disease, 65, 22–26.

Zong Z, Feng Y, McNally A. 2021. Carbapenem and colistin resistance in Enterobacter: Determinants and clones. Trends in Microbiology, 29, 473–476.